Trupanion, Inc. (TRUP)

Trupanion's stock price has fluctuated significantly over the past six months, decreasing by 34.1% year-to-date as of early May 2026. Key events include the Q4 2025 earnings release, where EPS missed estimates leading to downgrades, and the Q1 2026 earnings release, where EPS beat estimates but analysts remained cautious. Insider selling, including the CFO selling shares in March 2026, has also impacted investor conviction.

The pet insurance market exhibits seasonal demand patterns. The third quarter typically sees the highest volume for pet insurance claims due to seasonal pet health issues. May and the broader summer season are also noted as times when seasonal needs for pets may increase, potentially leading to more veterinary visits and a heightened demand for pet insurance coverage.

Trupanion, Inc. operates in the Financial Services sector, providing medical insurance for pets, mainly cats and dogs. Their core product is a customizable medical policy covering veterinary diagnostic tests, surgeries, hospital stays, and congenital or hereditary conditions. Trupanion also offers specialized products like PHI Direct and Furkin, particularly in Canada. Their patented Trupanion Express software facilitates direct payment to veterinarians, streamlining the claims process.

Trupanion's operations extend across the United States, Canada, Australia, Puerto Rico, and Continental Europe. The company's headquarters are located in Seattle, Washington, U.S., with a Canadian office in North Vancouver, British Columbia.

Trupanion generally maintains a positive brand reputation, particularly among veterinarians, who voted it #1 in America in a 2023 survey. The company emphasizes its lifelong coverage, direct-pay model, and engagement with the veterinary community. However, Trupanion's reputation has faced challenges, including past regulatory violations and recent customer complaints regarding denied claims and premium increases.

Trupanion, Inc. has a diverse ownership structure, with a significant portion held by institutional investors. Major institutional owners include BlackRock, Inc., Capital World Investors, and Aflac Inc. Key individual and insider owners include Dan Levitan, Maveron General Partner III LLC, and Darryl Rawlings, the company's founder and Chairman of the Board.